Machine Learning and NLP Improve Medication Reconciliation, Patient Safety
In late 2018, KDMC sought to improve patient safety and streamline the medication reconciliation process by automating EHR transcription of critical medication data. The solution KDMC came up with has contributed to increased patient safety and better health outcomes, as well as higher nurse productivity.
Promising Data on Opioids Detracts From Ongoing Problem: Postsurgical Dependence
U.S. overdose deaths—67.8% of which involve opioids—decreased last year for the first time in nearly three decades and are projected to decline another 3.4% this year. Other data show opioids are prescribed less often, and at lower dosages, than in the past.
Opioid Epidemic Linked to $205B in Excess Healthcare Spending Over 4 Years
The $205 billion attributable to excess healthcare spending between 2015 and 2018 included providing medical care for opioid addicts and infants born with neonatal opioid-related conditions, and other family members bearing costs associated with those diagnoses.
Q&A: Tim Vanderveen Discusses Advances in IV Therapy
In this interview, Tim Vanderveen, PharmD, a consultant with ICU Medical, discusses IV therapy and its impact on patient safety.
Use New Delays to Catch Up to More Stringent USP Requirements
Because new USP <800> Hazardous Drugs—Handling in Healthcare Settings refers to the other chapters, it is considered by USP to be “informational only” until the revisions are final. The Joint Commission has said it will continue to survey hospitals to the current USP compounding chapters but will expect hospitals to meet the requirements of local AHJs, as always.
USP Delays Revised Chapters; USP <800> to be ‘Informational’ Only
USP <800> will still take effect on December 1. The Healthcare Quality and Safety team at USP explained that it would only be “informational and not compendially applicable.”
Dangerous Wrong-Route Errors With Tranexamic Acid—A Major Cause for Concern
When given intraspinally instead of a local anesthetic, tranexamic acid is a potent neurotoxin with a mortality rate of about 50% and is almost always harmful to the patient. Survivors of intraspinal tranexamic acid injection often experience seizures, permanent neurological injury, and paraplegia.
Joint Commission Offers Drug Diversion Advice, Resources Amid Growing Opioid Epidemic
The alert newsletter, Quick Safety 48, was released in the April issue of Perspectives amid statistics The Joint Commission cited from both the U.S. Substance Abuse and Mental Health Services Administration and the American Nurses Association, which together suggest that 10% of healthcare workers in the U.S. are abusing drugs of some sort.
Q&A: ISMP President Discusses Medication Safety
In this interview, Michael R. Cohen, RPH, MS, ScD (hon.), DPS (hon.), FASHP, founder and president of the Institute for Safe Medication Practices, discusses the current state of medication safety.
New Sentinel Event Alert Highlights Risks of Direct Oral Anticoagulants
According to the Joint Commission alert, direct oral anticoagulants provide ease of use for patients, but they can lead to bleeding risks that could be serious and potentially life-threatening.